Literature DB >> 22631631

Type-specific incidence and persistence of HPV infection among young women: a prospective study in North India.

Palika Datta1, Neerja Bhatla, R M Pandey, Lalit Dar, A Rajkumar Patro, Shachi Vasisht, Alka Kriplani, Neeta Singh.   

Abstract

BACKGROUND: Infections with human papillomavirus (HPV) are highly prevalent among sexually active young women in India. However, not much is known about the incidence of type-specific human papillomavirus (HPV) infections and their patterns of persistence, especially in the Indian context.
OBJECTIVE: The objective of this study was to evaluate the rate of acquisition and persistence of HPV types in young women.
METHODS: Women residing in an urban slum in Delhi (n=1300) were followed for 24 months at 6 monthly intervals. Exfoliated cervical cells collected at each visit were tested for the presence of HPV DNA. Genotyping was performed using the reverse line blot assay.
RESULTS: The incidence rate for any HPV type was calculated to be 5 per 1000 women-months. Among high risk HPV types, HPV16 had the highest incidence rate followed by HPV59, HPV52 and HPV18, i.e., 3.0, 0.58, 0.41 and 0.35 women per 1000 women-months respectively. The persistence rate was higher for high-risk than low-risk HPV types. Among low-risk types, HPV42, HPV62, HPV84 and HPV89 were found to persist. Whereas almost all high risk types showed persistence, the highest rate was found in women with HPV types 16, 45, 67, 31, 51 and 59. The persistence rate for HPV16 infection was 45 per 1000 women-months.
CONCLUSION: Incident HPV infections and high risk HPV type-specific persistence were found to be high in our study population of young married women. Understanding the patterns of HPV infection may help plan appropriate strategies for prevention programs including vaccination and screening.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22631631     DOI: 10.7314/apjcp.2012.13.3.1019

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Authors:  Arati Mane; Vikrant V Sahasrabuddhe; Amit Nirmalkar; Arun R Risbud; Seema Sahay; Ramesh A Bhosale; Sten H Vermund; Sanjay M Mehendale
Journal:  J Clin Virol       Date:  2016-10-28       Impact factor: 3.168

Review 2.  Human papillomavirus and cervical cancer: an insight highlighting pathogenesis and targeting strategies.

Authors:  Prachi S Ojha; Meenaxi M Maste; Siddarth Tubachi; Vishal S Patil
Journal:  Virusdisease       Date:  2022-05-30

Review 3.  Epidemiology of cervical cancer with special focus on India.

Authors:  Aswathy Sreedevi; Reshma Javed; Avani Dinesh
Journal:  Int J Womens Health       Date:  2015-04-16

4.  Mucosal Alpha-Papillomavirus (HPV89) in a rare skin lesion.

Authors:  Francesca Paolini; Carlo Cota; Ada Amantea; Gianfranca Curzio; Aldo Venuti
Journal:  Virol J       Date:  2015-07-07       Impact factor: 4.099

5.  Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study.

Authors:  Angela Ri Meyrelles; Juliana D Siqueira; Pâmela P Dos Santos; Cristina B Hofer; Ronir R Luiz; Héctor N Seuánez; Gutemberg Almeida; Marcelo A Soares; Esmeralda A Soares; Elizabeth S Machado
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-02       Impact factor: 2.743

6.  Community-Based Prevalence of Genital Human Papilloma Virus (HPV) Infection: a Systematic Review and Meta-Analysis

Authors:  Sasidharanpillai Sabeena; Parvati V Bhat; Veena Kamath; Shashikala K Bhat; Sreekumaran Nair; Ravishankar n; Kiran Chandrabharani; Govindakarnavar Arunkumar
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

7.  HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.

Authors:  Rashmirani Senapati; Bhagyalaxmi Nayak; Shantanu Kumar Kar; Bhagirathi Dwibedi
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

8.  Composite Analysis of the Virome and Bacteriome of HIV/HPV Co-Infected Women Reveals Proxies for Immunodeficiency.

Authors:  Juliana D Siqueira; Gislaine Curty; Deng Xutao; Cristina B Hofer; Elizabeth S Machado; Héctor N Seuánez; Marcelo A Soares; Eric Delwart; Esmeralda A Soares
Journal:  Viruses       Date:  2019-05-07       Impact factor: 5.048

9.  Estimating incidence rates of grouped HPV types: A systematic review and comparison of the impact of different epidemiological assumptions.

Authors:  Vita W Jongen; Daniëla K van Santen; Catharina J Alberts; Maarten F Schim van der Loeff
Journal:  Papillomavirus Res       Date:  2019-10-07

10.  Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.

Authors:  Rengaswamy Sankaranarayanan; Priya Ramesh Prabhu; Michael Pawlita; Tarik Gheit; Neerja Bhatla; Richard Muwonge; Bhagwan M Nene; Pulikottil Okuru Esmy; Smita Joshi; Usha Rani Reddy Poli; Parimal Jivarajani; Yogesh Verma; Eric Zomawia; Maqsood Siddiqi; Surendra S Shastri; Kasturi Jayant; Sylla G Malvi; Eric Lucas; Angelika Michel; Julia Butt; Janki Mohan Babu Vijayamma; Subha Sankaran; Thiraviam Pillai Rameshwari Ammal Kannan; Rintu Varghese; Uma Divate; Shila Thomas; Geeta Joshi; Martina Willhauck-Fleckenstein; Tim Waterboer; Martin Müller; Peter Sehr; Sanjay Hingmire; Alka Kriplani; Gauravi Mishra; Sharmila Pimple; Radhika Jadhav; Catherine Sauvaget; Massimo Tommasino; Madhavan Radhakrishna Pillai
Journal:  Lancet Oncol       Date:  2015-12-02       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.